Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.
DOJ says ex-Binance CEO Changpeng Zhao should serve three years in prison: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry….
Ukraine uses long-range ATACMS against Russia for the first time
The U.S. provided Ukraine with the powerful ballistic missiles this month but did not reveal it publicly for operational security reasons, a National Security Council spokesperson said.
Apple shares could be primed for a rebound, according to the charts
Apple, the most important name in the stock market, has not been acting like it recently. That could change.
Stocks making the biggest moves midday: Tesla, Hilton, Boeing, Mattel and more
These are the stocks posting the largest moves in midday trading.
TikTok creators fear for their livelihoods after U.S. lawmakers pass bill that could lead to ban
A TikTok ban could take years due to potential legal challenges, but creators worry about how they’ll make a living if it goes away.
European markets close lower as momentum falters; tech stocks hold gains
European markets closed lower Wednesday, shedding gains from the morning.
Tech companies are heavily exposed to China, putting gains at risk, Piper Sandler says
Tech companies are especially vulnerable to any weakness in China, with semiconductor businesses notably generating more than 30% of their sales in the country.
Biden signs Israel, Ukraine, TikTok bill into law
TikTok vowed to legally challenge the measure if President Joe Biden signed it into law.
Meta plunges 16% on weak revenue guidance even as first-quarter results top estimates
Meta beat on the top and bottom lines in its earnings report on Wednesday, but the stock sank on disappointing guidance.
